TR199900636T2 - Anti-tümör ajanlari olarak ikameli/katkili heterosaykillar. - Google Patents
Anti-tümör ajanlari olarak ikameli/katkili heterosaykillar.Info
- Publication number
- TR199900636T2 TR199900636T2 TR1999/00636T TR9900636T TR199900636T2 TR 199900636 T2 TR199900636 T2 TR 199900636T2 TR 1999/00636 T TR1999/00636 T TR 1999/00636T TR 9900636 T TR9900636 T TR 9900636T TR 199900636 T2 TR199900636 T2 TR 199900636T2
- Authority
- TR
- Turkey
- Prior art keywords
- formula
- heterocycles
- doped
- substituted
- tumor agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bu bulus, anti-kanser ajanlari olarak fayda arzeden, R1-R7, W,X,Y ve Z'nin tarifnamede tayin edilen degerlerden herhangi birisine sahip oldugu formül (I)'i havi bilesikleri, ve bunlarin farmasötik yönden kabul edilebilir tuzlarini ortaya koymaktadir. Ayrica, formül (I)'i havi bir veya daha fazla bilesigi ihtiva eden farmasötik kompozisyonlar, formül (I)'i havi bilesiklerin hazirlanmasina yönelik prosesler, ve formül (I)'i havi bilesiklerin hazirlanmasinda faydali olan ara maddeler de tarif edilmektedir. (Formül(I))
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2651196P | 1996-09-23 | 1996-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199900636T2 true TR199900636T2 (tr) | 1999-10-21 |
Family
ID=21832257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/00636T TR199900636T2 (tr) | 1996-09-23 | 1997-09-23 | Anti-tümör ajanlari olarak ikameli/katkili heterosaykillar. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5981541A (tr) |
EP (1) | EP0950054A1 (tr) |
JP (1) | JP2001501197A (tr) |
KR (1) | KR20000048537A (tr) |
AU (1) | AU725938B2 (tr) |
BR (1) | BR9711296A (tr) |
CA (1) | CA2266321A1 (tr) |
CZ (1) | CZ102499A3 (tr) |
IL (1) | IL129096A0 (tr) |
NO (1) | NO991384L (tr) |
NZ (1) | NZ334954A (tr) |
PL (1) | PL332416A1 (tr) |
TR (1) | TR199900636T2 (tr) |
WO (1) | WO1998012181A1 (tr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6063801A (en) * | 1998-02-12 | 2000-05-16 | Rutgers, The State University Of New Jersey | Heterocyclic topoisomerase poisons |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US8133421B2 (en) * | 1999-02-23 | 2012-03-13 | Warsaw Orthopedic, Inc. | Methods of making shaped load-bearing osteoimplant |
US20070233272A1 (en) * | 1999-02-23 | 2007-10-04 | Boyce Todd M | Shaped load-bearing osteoimplant and methods of making same |
US6740650B2 (en) | 1999-10-29 | 2004-05-25 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
GB9928542D0 (en) * | 1999-12-02 | 2000-02-02 | Xenova Ltd | Pharmaceutical compounds |
US20030139409A1 (en) | 1999-12-02 | 2003-07-24 | John Milton | Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
US6686371B2 (en) * | 2000-03-27 | 2004-02-03 | Akzo Nobel N.V. | Non-steroidal, tetracylic compounds for estrogen-related treatments |
KR100381716B1 (ko) * | 2000-10-09 | 2003-04-26 | 한국화학연구원 | 항암활성을 가지는 아크리딘 유도체 |
ATE390923T1 (de) * | 2001-11-14 | 2008-04-15 | Univ Rutgers | Topoisomerase-giftmittel |
DE60228484D1 (de) * | 2001-11-14 | 2008-10-02 | Univ Rutgers | Cytotoxische mittel |
JP4628675B2 (ja) * | 2001-11-14 | 2011-02-09 | ラトガーズ,ザ ステイト ユニバーシティ | 可溶化トポイソメラーゼ毒 |
CA2467279A1 (en) | 2001-11-14 | 2003-06-26 | Edmond J. Lavoie | Solubilized topoisomerase poison agents |
US6992089B2 (en) | 2002-08-09 | 2006-01-31 | Rutgers, The University Of New Jersey | Nitro and amino substituted topoisomerase agents |
WO2004014862A1 (en) * | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted heterocycles as topoisomerase i targeting agents |
AU2003265406A1 (en) | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted topoisomerase agents |
WO2004044174A2 (en) | 2002-11-12 | 2004-05-27 | Rutgers, The State University | Topoisomerase-targeting agents |
ES2401563T3 (es) | 2009-03-06 | 2013-04-22 | Rutgers, The State University Of New Jersey | Derivados de metilendioxibenzo [I]fenantridina usados para tratar el cáncer |
WO2010127363A1 (en) | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
CA2799989A1 (en) * | 2010-05-21 | 2011-11-24 | Shanghai Institute Of Pharmaceutical Industry | Polycyclic quinazolines, preparation thereof, and use thereof |
CN102351870B (zh) * | 2011-08-25 | 2014-03-12 | 中山大学 | 一种苯并吖啶衍生物的制备方法及其作为抗癌药物的用途 |
CN105669551B (zh) * | 2015-12-02 | 2018-04-17 | 广西中医药大学 | 7‑苯并(c)吖啶对氟苯甲酰胺基硫脲及其制备方法和用途 |
US11091498B2 (en) | 2016-04-04 | 2021-08-17 | Rutgers, The State University Of New Jersey | Topoisomerase poisons |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2981731A (en) * | 1961-04-25 | Acridine derivatives | ||
US26065A (en) * | 1859-11-08 | Improvement in cotton-gins | ||
USRE26065E (en) | 1966-07-19 | Folybenzimidazoles and their preparation | ||
US2985661A (en) * | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
US2915523A (en) * | 1956-12-03 | 1959-12-01 | Parke Davis & Co | Benzacridine compounds |
US3272707A (en) * | 1964-07-17 | 1966-09-13 | Smith Kline French Lab | Pharmaceutical compositions and methods for their use |
CH420045A (de) * | 1964-09-01 | 1967-03-15 | Ciba Geigy | Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien |
US3267107A (en) * | 1964-09-17 | 1966-08-16 | American Home Prod | 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines |
US3849561A (en) * | 1964-10-20 | 1974-11-19 | S Naruto | Anti-peptic ulcer substance from corydalis tubers |
DE1670684A1 (de) * | 1966-04-01 | 1970-12-03 | Hoechst Ag | Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten |
JPS4942700A (tr) * | 1972-08-25 | 1974-04-22 | ||
US4980344A (en) * | 1982-05-14 | 1990-12-25 | Maroko Peter R | Compositions for improving circulatory performance |
JPS61130289A (ja) * | 1984-11-29 | 1986-06-18 | Ss Pharmaceut Co Ltd | 13−プロピルベルベリンの塩 |
US5244903A (en) * | 1987-03-31 | 1993-09-14 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
JP2700475B2 (ja) * | 1988-07-30 | 1998-01-21 | コニカ株式会社 | 非線形光学材料および非線形光学素子 |
US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
US5106863A (en) * | 1990-03-26 | 1992-04-21 | Ortho Pharmaceutical Corporation | Substituted imidazole and pyridine derivatives |
US5135934A (en) * | 1990-07-06 | 1992-08-04 | Du Pont Merck Pharmaceutical Company | 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
US5126351A (en) * | 1991-01-24 | 1992-06-30 | Glaxo Inc. | Antitumor compounds |
US5223506A (en) * | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
US5428040A (en) * | 1993-08-31 | 1995-06-27 | The Du Pont Merck Pharmaceutical Company | Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
EP0721942B1 (en) * | 1993-09-28 | 2002-06-05 | Kyowa Hakko Kogyo Co., Ltd. | Tetracyclic compound |
-
1997
- 1997-09-23 EP EP97944388A patent/EP0950054A1/en not_active Ceased
- 1997-09-23 KR KR1019990702452A patent/KR20000048537A/ko not_active Application Discontinuation
- 1997-09-23 AU AU45897/97A patent/AU725938B2/en not_active Ceased
- 1997-09-23 CA CA002266321A patent/CA2266321A1/en not_active Abandoned
- 1997-09-23 US US08/935,777 patent/US5981541A/en not_active Expired - Lifetime
- 1997-09-23 TR TR1999/00636T patent/TR199900636T2/tr unknown
- 1997-09-23 WO PCT/US1997/017012 patent/WO1998012181A1/en not_active Application Discontinuation
- 1997-09-23 JP JP10515004A patent/JP2001501197A/ja active Pending
- 1997-09-23 PL PL97332416A patent/PL332416A1/xx unknown
- 1997-09-23 BR BR9711296A patent/BR9711296A/pt unknown
- 1997-09-23 CZ CZ991024A patent/CZ102499A3/cs unknown
- 1997-09-23 NZ NZ334954A patent/NZ334954A/xx unknown
- 1997-09-23 IL IL12909697A patent/IL129096A0/xx unknown
-
1999
- 1999-03-22 NO NO991384A patent/NO991384L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2266321A1 (en) | 1998-03-26 |
EP0950054A1 (en) | 1999-10-20 |
US5981541A (en) | 1999-11-09 |
AU4589797A (en) | 1998-04-14 |
IL129096A0 (en) | 2000-02-17 |
PL332416A1 (en) | 1999-09-13 |
JP2001501197A (ja) | 2001-01-30 |
NO991384D0 (no) | 1999-03-22 |
BR9711296A (pt) | 1999-08-17 |
NO991384L (no) | 1999-05-20 |
AU725938B2 (en) | 2000-10-26 |
WO1998012181A1 (en) | 1998-03-26 |
CZ102499A3 (cs) | 1999-09-15 |
NZ334954A (en) | 2000-08-25 |
KR20000048537A (ko) | 2000-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199900636T2 (tr) | Anti-tümör ajanlari olarak ikameli/katkili heterosaykillar. | |
TR200200225T2 (tr) | İkameli okzo azahetrosiklil bileşikleri | |
PL348451A1 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
TR200101567T2 (tr) | Yeni triazolo(4.5-D)pirimidin bileşimleri. | |
TR199900920T2 (tr) | Nafthiridin türevleri. | |
BR0016396A (pt) | Novos antagonistas do receptor p2x7 para uso no tratamento de doenças inflamatórias, imunes ou cardiovasculares | |
TR200101126T2 (tr) | İkameli fenil türevleri, hazırlanma ve kullanımları | |
TR199802344A2 (tr) | Ikame edilmis imidazolidin türevleri | |
CA2274464A1 (en) | Ketobenzamides as calpain inhibitors | |
TR200101412T2 (tr) | Yeni bileşikler. | |
RU94042922A (ru) | Новые соединения, способы их получения, фармацевтическая композиция | |
MX9702382A (es) | Nuevos derivados de pirimidona con actividad antifungica. | |
TR200100075T2 (tr) | 2-Kuinolon ihtiva eden farmasötik bileşimler | |
CO4910133A1 (es) | Antagonistas de 5-h[1f] | |
TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
TR199900732T2 (tr) | PDE IV inhibe eden 2-siyanoiminoimidazol türevleri. | |
TR200002418T2 (tr) | Antitümör ajanları | |
TR200100462T2 (tr) | Muskarinik agonistleri ve antagonistleri | |
TR200002380T2 (tr) | Yeni triazolo (4,5-d) pirimidin bileşikleri | |
TR199801268T2 (tr) | Tasikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler. | |
TR200101978T2 (tr) | 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri. | |
CA2152771A1 (en) | 7-o-ethers of taxane derivatives | |
PT1427417E (pt) | Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos |